Benzinga | Jun 30, 2021 09:32AM EDT

Craig-Hallum Maintains Buy on Avid Bioservices, Raises Price Target to $29

Craig-Hallum analyst Matt Hewitt maintains Avid Bioservices (NASDAQ:CDMO) with a Buy and raises the price target from $21 to $29.